Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,014 | 63,737 | 63,062 | 70,834 | 32,203 |
| Receivables | 33,862 | 68,142 | 56,887 | 56,424 | 72,718 |
| Inventories | 27,240 | 278,753 | 27,815 | 24,383 | 25,594 |
| Other current assets | 0 | -250,877 | 0 | 0 | 0 |
| TOTAL | $167,302 | $173,975 | $163,962 | $172,364 | $149,317 |
| Non-Current Assets | |||||
| PPE Net | 30,325 | 31,084 | 30,738 | 31,263 | 31,302 |
| Intangibles | 290,179 | 431,743 | 574,376 | 591,245 | 674,055 |
| Other Non-Current Assets | 6,367 | 7,034 | 7,070 | 752 | 800 |
| TOTAL | $326,871 | $469,861 | $612,185 | $623,260 | $706,156 |
| Total Assets | $494,173 | $643,835 | $776,147 | $795,624 | $855,472 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 398 | 992 | 795 | 1,774 | 6,066 |
| Accounts payable and accrued liabilities | 9,905 | 18,917 | 20,591 | 24,871 | 27,861 |
| Accrued Expenses | 66,076 | 75,525 | 72,479 | 87,237 | 81,577 |
| TOTAL | $78,591 | $97,904 | $96,492 | $114,001 | $115,614 |
| Non-Current Liabilities | |||||
| Long Term Debt | 267,661 | 267,366 | 267,080 | 266,803 | 310,009 |
| Other Non-Current Liabilities | 3,677 | 6,186 | 6,380 | 2,541 | 1,073 |
| TOTAL | $273,886 | $288,021 | $298,417 | $297,776 | $324,355 |
| Total Liabilities | $352,476 | $385,925 | $394,909 | $411,777 | $439,969 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,926 | 52,519 | 52,519 | 52,519 | 52,519 |
| Common Shares | 522 | 525 | 525 | 525 | N/A |
| Retained earnings | -346,380 | -233,214 | -108,560 | -102,120 | N/A |
| Other shareholders' equity | -2,229 | -1,846 | -1,846 | -1,846 | 415,503 |
| TOTAL | $141,697 | $257,911 | $381,238 | $383,847 | $415,503 |
| Total Liabilities And Equity | $494,173 | $643,835 | $776,147 | $795,624 | $855,472 |